IBIO
Price
$2.48
Change
+$0.06 (+2.48%)
Updated
Dec 20 closing price
STOK
Price
$11.68
Change
+$0.38 (+3.36%)
Updated
Dec 20 closing price
73 days until earnings call
Ad is loading...

IBIO vs STOK

Header iconIBIO vs STOK Comparison
Open Charts IBIO vs STOKBanner chart's image
iBio
Price$2.48
Change+$0.06 (+2.48%)
Volume$61.52K
CapitalizationN/A
Stoke Therapeutics
Price$11.68
Change+$0.38 (+3.36%)
Volume$1.18M
CapitalizationN/A
IBIO vs STOK Comparison Chart
Loading...
IBIO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
STOK
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
IBIO vs. STOK commentary
Dec 23, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is IBIO is a Hold and STOK is a Hold.

COMPARISON
Comparison
Dec 23, 2024
Stock price -- (IBIO: $2.48 vs. STOK: $11.68)
Brand notoriety: IBIO and STOK are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: IBIO: 60% vs. STOK: 222%
Market capitalization -- IBIO: $22.69M vs. STOK: $618.65M
IBIO [@Biotechnology] is valued at $22.69M. STOK’s [@Biotechnology] market capitalization is $618.65M. The market cap for tickers in the [@Biotechnology] industry ranges from $464.4B to $0. The average market capitalization across the [@Biotechnology] industry is $2.57B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

IBIO’s FA Score shows that 1 FA rating(s) are green whileSTOK’s FA Score has 0 green FA rating(s).

  • IBIO’s FA Score: 1 green, 4 red.
  • STOK’s FA Score: 0 green, 5 red.
According to our system of comparison, both IBIO and STOK are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

IBIO’s TA Score shows that 3 TA indicator(s) are bullish while STOK’s TA Score has 3 bullish TA indicator(s).

  • IBIO’s TA Score: 3 bullish, 6 bearish.
  • STOK’s TA Score: 3 bullish, 8 bearish.
According to our system of comparison, IBIO is a better buy in the short-term than STOK.

Price Growth

IBIO (@Biotechnology) experienced а +7.36% price change this week, while STOK (@Biotechnology) price change was -3.15% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -2.22%. For the same industry, the average monthly price growth was -1.31%, and the average quarterly price growth was +0.77%.

Reported Earning Dates

IBIO is expected to report earnings on May 15, 2023.

STOK is expected to report earnings on Mar 05, 2025.

Industries' Descriptions

@Biotechnology (-2.22% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
STOK($619M) has a higher market cap than IBIO($22.7M). STOK YTD gains are higher at: 122.053 vs. IBIO (81.022).
IBIOSTOKIBIO / STOK
Capitalization22.7M619M4%
EBITDAN/AN/A-
Gain YTD81.022122.05366%
P/E RatioN/AN/A-
RevenueN/AN/A-
Total Cash55.1MN/A-
Total Debt17.3MN/A-
FUNDAMENTALS RATINGS
IBIO: Fundamental Ratings
IBIO
OUTLOOK RATING
1..100
69
VALUATION
overvalued / fair valued / undervalued
1..100
84
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
99
PRICE GROWTH RATING
1..100
38
P/E GROWTH RATING
1..100
1
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
IBIOSTOK
RSI
ODDS (%)
N/A
Bullish Trend 3 days ago
81%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
82%
Bullish Trend 3 days ago
84%
Momentum
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
83%
MACD
ODDS (%)
Bearish Trend 3 days ago
88%
Bearish Trend 3 days ago
76%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
82%
Bearish Trend 3 days ago
84%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
84%
Bullish Trend 3 days ago
83%
Advances
ODDS (%)
Bullish Trend 3 days ago
79%
Bullish Trend 3 days ago
86%
Declines
ODDS (%)
Bearish Trend 10 days ago
90%
Bearish Trend 5 days ago
82%
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
90%
Bearish Trend 3 days ago
84%
Aroon
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
88%
View a ticker or compare two or three
Ad is loading...
IBIO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
STOK
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GME29.820.82
+2.83%
GameStop Corp
AAPL254.494.70
+1.88%
Apple
SPY591.157.02
+1.20%
SPDR® S&P 500® ETF Trust
BTC.X97224.730000-531.203100
-0.54%
Bitcoin cryptocurrency
TSLA421.06-15.11
-3.46%
Tesla

IBIO and

Correlation & Price change

A.I.dvisor indicates that over the last year, IBIO has been loosely correlated with REPL. These tickers have moved in lockstep 38% of the time. This A.I.-generated data suggests there is some statistical probability that if IBIO jumps, then REPL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IBIO
1D Price
Change %
IBIO100%
+2.48%
REPL - IBIO
38%
Loosely correlated
+4.00%
LIANY - IBIO
37%
Loosely correlated
+4.87%
TPIA - IBIO
37%
Loosely correlated
N/A
NUVB - IBIO
35%
Loosely correlated
-0.37%
STOK - IBIO
32%
Poorly correlated
+3.36%
More

STOK and

Correlation & Price change

A.I.dvisor indicates that over the last year, STOK has been loosely correlated with NUVB. These tickers have moved in lockstep 52% of the time. This A.I.-generated data suggests there is some statistical probability that if STOK jumps, then NUVB could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To STOK
1D Price
Change %
STOK100%
+3.36%
NUVB - STOK
52%
Loosely correlated
-0.37%
STRO - STOK
48%
Loosely correlated
+3.30%
INZY - STOK
46%
Loosely correlated
+6.41%
QTTB - STOK
44%
Loosely correlated
+7.49%
DNLI - STOK
43%
Loosely correlated
-0.19%
More